Sun Pharma Q2 net profit rises 5% to Rs 2,375 crore

Sun Pharmaceutical Industries Ltd. reported second-quarter consolidated net profit grew 5% to Rs 2,375.5 crore from the year-earlier period.  Gross sales at Rs 12,003 crore, grew 11.0% Year on Year (YoY). India formulation sales at Rs 38,42.5 crore, grew 11.1% YoY while U.S. formulation sales increased 4.2% YoY to $430 million.

The company said it’s global specialty sales increased 19.3% YoY to $240 million and  global specialty sales accounted for 16.4% of Q2FY24 sales.

Emerging Markets formulation sales at $284 million, grew 9.4% YoY and Rest of World formulation sales increased 13.7% YoY to $206 million, the company said in a filing.

Dilip Shanghvi, Managing Director in a statement said, “U.S. FDA’s acceptance of deuruxolitinib NDA for treatment of moderate to severe alopecia areata marks an important milestone.

“There are limited treatment options for alopecia areata and deuruxolitinib should make a meaningful difference in patient lives, once approved,” he said.

“Similarly, another late stage candidate Nidlegy will potentially complement our Odomzo franchise. Nidlegy’s recent positive phase-3 data in patients with locally advanced fully resectable melanoma positions us to provide patient solutions across a broad spectrum of skin cancers,” he added.

Related Posts

  • Pharma
  • December 23, 2024
  • 82 views
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

  • Pharma
  • December 23, 2024
  • 112 views
NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt